Meeting
2018 ASCO Annual Meeting
Cyclophosphamide (Cy) pharmacogenetics (PGx) in allogeneic stem cell transplant (SCT) patients (pts) receiving Cy, fludarabine, total body irradiation and post-transplant Cy (FluCyTBI-postCy).
Authors
Jai Narendra Patel
Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC
Jai Narendra Patel , Qing Zhang , Issam Hamadeh , Nury Steuerwald , Alicia Hamilton , Jonathan Michael Gerber , Michael Richard Grunwald , Lawrence Druhan , Jiaxian He , Belinda Rene Avalos , Edward Alan Copelan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Allogenic Stem Cell Transplantation
Citation
J Clin Oncol 36, 2018 (suppl; abstr 7058)
DOI
10.1200/JCO.2018.36.15_suppl.7058
Abstract #
7058
Poster Bd #
118
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
The impact of genetic variability on severe toxicity of (neo-) adjuvant chemotherapy in breast cancer patients receiving 5-fluorouracil, epirubicin, and cyclofosfamide (FEC).
First Author: Christof Vulsteke
Poster
2019 Supportive Care in Oncology Symposium
Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic.
First Author: Jai Narendra Patel
Poster
2022 ASCO Annual Meeting
Non-myeloablative allogeneic blood or marrow transplantation (AlloBMT) with post-transplant cyclophosphamide (PTCy) for peripheral T-cell lymphoma (PTCL): Improved outcomes with peripheral blood (PB) allografts and increased total body irradiation (TBI) to 400 cGV.
First Author: Cole Harris Sterling
Poster
2019 ASCO Annual Meeting
A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine and total body irradiation (Flu/TBI).
First Author: Omer Hassan JAMY